These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4337228)

  • 1. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx.
    Olefsky J; Kempson R; Jones H; Reaven G
    N Engl J Med; 1972 Apr; 286(14):740-5. PubMed ID: 4337228
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

  • 4. [A sporadic case of vitamin D-resistant rickets in an adult].
    Chiesa A; Barbera G; Scassa E
    Minerva Med; 1983 Feb; 74(6):255-60. PubMed ID: 6298662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic osteomalacia: induced by tumor, cured by surgery.
    Ahn JM; Kim HJ; Cha CM; Kim J; Yim SG; Kim HJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):636-41. PubMed ID: 17307367
    [No Abstract]   [Full Text] [Related]  

  • 6. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset vitamin-D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy.
    Riggs BL; Sprague RG; Jowsey J; Maher FT
    N Engl J Med; 1969 Oct; 281(14):762-6. PubMed ID: 5807923
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 9. Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets.
    McEnery PT; Silverman FN; West CD
    J Pediatr; 1972 May; 80(5):763-74. PubMed ID: 5018387
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired hypophosphataemic vitamin D resistant rickets in black children.
    Pettifor JM; Ross FP; Quirk M; Moodley GP; Cavaleros M
    Bone Miner; 1986 Sep; 1(4):307-19. PubMed ID: 2849486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin-D-resistant rickets.
    Earp HS; Ney RL; Gitelman HJ; Richman R; DeLuca HF
    N Engl J Med; 1970 Sep; 283(12):627-30. PubMed ID: 4317911
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy.
    Yoshioka K; Nagata R; Ueda M; Yamaguchi T; Konishi Y; Hosoi M; Inoue T; Yamanaka K; Iwai Y; Sato T
    Intern Med; 2006; 45(20):1157-60. PubMed ID: 17106161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
    Cundy T; Kanis JA; Heynen G; Earnshaw M; Clemens TL; O'Riordan JL; Merrett AL; Compston JE
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):883-5. PubMed ID: 6279228
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-induced osteomalacia masking primary hyperparathyroidism.
    Elfenbein DM; Weber TJ; Scheri RP
    Surgery; 2012 Dec; 152(6):1256-8. PubMed ID: 23158192
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiopathological aspects of the parathyroid hormone and calcitonin in childhood].
    Tanas R; Turchi S; Platé L; Ciacci L; Ventura D; Pirazzoli P; Cicognani A; Capelli M; Cacciari E
    Minerva Pediatr; 1979 Dec; 31(23):1669-76. PubMed ID: 233430
    [No Abstract]   [Full Text] [Related]  

  • 16. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.
    Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP
    J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin-D-resistant rickets: results of 12 months combined vitamin D and phosphate therapy].
    Krohn HP; Brandis M; Brodehl J; Offner G
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):417-9. PubMed ID: 180401
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia.
    Chattopadhyay A; Bhansali A; Mohanty SK; Khandelwal N; Mathur SK; Dash RJ
    J Pediatr Endocrinol Metab; 2003; 16(6):893-6. PubMed ID: 12948303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypophosphatemic vitamin D refractory rickets and osteomalacia.
    Parfitt AM
    Orthop Clin North Am; 1972 Nov; 3(3):653-80. PubMed ID: 4344934
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.
    Loeffler RD; Sherman FC
    Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.